0001209191-17-033212.txt : 20170517 0001209191-17-033212.hdr.sgml : 20170517 20170517170237 ACCESSION NUMBER: 0001209191-17-033212 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170517 DATE AS OF CHANGE: 20170517 EFFECTIVENESS DATE: 20170517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OX2 Therapeutics, Inc. CENTRAL INDEX KEY: 0001704490 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-286958 FILM NUMBER: 17852420 BUSINESS ADDRESS: STREET 1: 16632 IREDALE PATH CITY: LAKEVILLE STATE: MN ZIP: 55044 BUSINESS PHONE: 612-309-7653 MAIL ADDRESS: STREET 1: 16632 IREDALE PATH CITY: LAKEVILLE STATE: MN ZIP: 55044 D 1 primary_doc.xml X0707 D LIVE 0001704490 OX2 Therapeutics, Inc. 5138 Hanover Drive Mound MN MINNESOTA 55364 612-309-7653 DELAWARE None None Corporation true 2016 Jeff Liter 5138 Hanover Drive Mound MN MINNESOTA 55364 Executive Officer Promoter Sumant Dhawan 5138 Hanover Drive Mound MN MINNESOTA 55364 Executive Officer Director Mike Olin 5138 Hanover Drive Mound MN MINNESOTA 55364 Director Christopher Moertel 5138 Hanover Drive Mound MN MINNESOTA 55364 Director Thomas Martinson 5138 Hanover Drive Mound MN MINNESOTA 55364 Director Ben Oehler 5138 Hanover Drive Mound MN MINNESOTA 55364 Director Biotechnology Decline to Disclose 06b false 2017-03-29 false true true true false 0 3060997 305002 2755995 (a) includes $3,000,000 equity offering, plus warrants to purchase up to 36,968 shares of common stock at $1.65 per share, which may never be exercised. false 4 0 0 0 false OX2 Therapeutics, Inc. /s/ Jeff Liter Jeff Liter President 2017-05-17